Report title: Belgium Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
from Global Markets Direct - Market Research
125 page report published Sep 28, 2009

Price $2,500.00 available for immediate download
Report Overview
 
Table of Contents
 
Search Inside
 
About Global Markets Direct - Market...

SummaryThis report is an essential source for in-depth information and data relating to Belgium neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the neurology devices market in BelgiumScope- The report provides information on the neurology devices market in Belgium. - Details on key segments and catergories such as CSF Management, Neurosurgical Products, Neurostimulation Devices, Interventional Neurology, and Radiosurgery. - Total revenues, products sold, end users, and average pricing.- Market shares of all the key competitors such as Elekta AB, Medtronic, Inc., Boston Scientific Corporation, Cordis Corporation, and ev3 Inc. - Key pipeline products that are set to shape the market, broken down by sector. - Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.- Key mergers and acquisitions, partnerships, private equity investments and IPOs. - Customer, hospitals and physicians data.Reasons to buy- Gain a strong understanding of the neurology devices market in Belgium.- Evaluate and compare the attractiveness of the market in the country. - Identify growth segments and opportunities in each industry sector within the country.- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.- Analyze the competitiveness of the market in the country and identify hotspots. - Develop strategies based on the latest product, brand, expansion and research and development news in the country. - Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Source: Global Markets Direct
Document ID: GMDME1098ICR
Country: Belgium
Industry: Medical Devices & Diagnostics
Free Sample: Click Here to Download
Format:
PDF Adobe Acrobat

Sections
TitleStarting PageNumber of Pages
1 Table of Contents210
1.1 List of Tables73
1.2 List of Figures102
2 Introduction121
2.1 What Is This Report About?121
3 Definitions of Markets Covered in This Report133
3.1 Neurology Devices131
3.2 CSF Management131
3.2.1 Hydrocephalus Shunts131
3.2.2 ICP Monitoring Devices131
3.3 Interventional Neurology131
3.3.1 Aneurysm Clips131
3.3.2 Embolic Systems131
3.3.3 Navigational Systems131
3.4 Neurostimulation Devices131
3.4.1 Deep Brain Stimulators141
3.4.2 Spinal Cord Stimulators141
3.4.3 Vagus Nerve Stimulators141
3.5 Neurosurgical Products141
3.5.1 Neuroendoscopes141
3.6 Radiosurgery141
3.6.1 CyberKnife Radiosurgery141
3.6.2 GammaKnife Radiosurgery142
4 Healthcare Sector Review168
4.1 Healthcare Expenditure163
4.2 Healthcare Infrastructure191
4.2.1 Healthcare Personnel Data201
4.2.2 Healthcare Facilities Data211
4.3 Healthcare Policy 222
5 Regulation System 2414
5.1 Medical Equipment Approval Process241
5.1.1 Classification 258
5.1.2 Conformity Assessment Process 331
5.1.2.1 Class I devices331
5.1.2.2 Class IIa devices341
5.1.2.3 Class IIb devices351
5.1.2.4 Class III devices361
5.2 Notification Fee 371
6 Pricing and Reimbursement381
6.1 Reimbursement Policies 381
7 Distribution Structure391
8 Neurology Devices In Belgium409
8.1 Neurology Devices, Belgium, Overall Revenue ($ mn), 2000-2015406
8.2 Neurology Devices, Belgium, Category Volume (Units), 2000-2015462
8.3 Neurology Devices, Belgium, Company Share (2007-2008)481
9 CSF Management In Belgium497
9.1 CSF Management Overall Revenue (2000-2015) 492
9.2 CSF Management Overall Volume (2000-2015) 512
9.3 CSF Management Average Price (2000-2015) 531
9.4 CSF Management Distribution Share (2007-2008) 541
9.5 CSF Management, Belgium, Company Share (2007-2008)551
10 Interventional Neurology In Belgium5615
10.1 Interventional Neurology Overall Revenue (2000-2015) 562
10.1.1 Embolic Systems Revenue (2000-2015)582
10.1.2 Navigational Systems Revenue (2000-2015)602
10.2 Interventional Neurology Overall Volume (2000-2015) 622
10.2.1 Embolic Systems Revenue (2000-2015)642
10.2.2 Navigational Systems Revenue (2000-2015)662
10.3 Interventional Neurology Average Price (2000-2015) 681
10.4 Interventional Neurology Distribution Share (2007-2008) 691
10.5 Interventional Neurology, Belgium, Company Share (2007-2008)701
11 Neurostimulation Devices In Belgium717
11.1 Neurostimulation Devices Overall Revenue (2000-2015) 712
11.2 Neurostimulation Devices Overall Volume (2000-2015) 732
11.3 Neurostimulation Devices Average Price (2000-2015) 751
11.4 Neurostimulation Devices Distribution Share (2007-2008) 761
11.5 Neurostimulation Devices, Belgium, Company Share (2007-2008)771
12 Neurosurgical Products In Belgium787
12.1 Neurosurgical Products Overall Revenue (2000-2015) 782
12.2 Neurosurgical Products Overall Volume (2000-2015) 802
12.3 Neurosurgical Products Average Price (2000-2015) 821
12.4 Neurosurgical Products Distribution Share (2007-2008) 831
12.5 Neurosurgical Products, Belgium, Company Share (2007-2008)841
13 Radiosurgery In Belgium857
13.1 Radiosurgery Overall Revenue (2000-2015) 852
13.2 Radiosurgery Overall Volume (2000-2015) 872
13.3 Radiosurgery Average Price (2000-2015) 891
13.4 Radiosurgery Distribution Share (2007-2008) 901
13.5 Radiosurgery, Belgium, Company Share (2007-2008)911
14 Overview of Key Companies in Belgium Neurology Devices Market9229
14.1 Medtronic, Inc. 921
14.1.1 Company Overview921
14.1.2 Medtronic, Inc. Pipeline Products931
14.1.2.1 Medtronic, Inc. Pipeline Products By Equipment Type932
14.1.2.2 Medtronic, Inc. Pipeline Products By Development Stage952
14.1.2.3 Medtronic, Inc. Pipeline Products By Therapy Area972
14.1.2.4 Medtronic, Inc. Pipeline Products By Clinical Trials991
14.1.2.5 Medtronic, Inc. Pipeline Products By News Summary1002
14.2 Boston Scientific Corporation 1021
14.2.1 Company Overview1021
14.2.2 Boston Scientific Corporation Pipeline Products1031
14.2.2.1 Boston Scientific Corporation Pipeline Products By Equipment Type1031
14.2.2.2 Boston Scientific Corporation Pipeline Products By Development Stage1041
14.2.2.3 Boston Scientific Corporation Pipeline Products By Therapy Area1051
14.2.2.4 Boston Scientific Corporation Pipeline Products By Clinical Trials1061
14.2.2.5 Boston Scientific Corporation Pipeline Products By News Summary1071
14.3 Cordis Corporation 1081
14.3.1 Company Overview1081
14.4 Elekta AB 1081
14.4.1 Company Overview1081
14.5 Cyberonics, Inc. 1091
14.5.1 Company Overview1091
14.5.2 Cyberonics, Inc. Pipeline Products1091
14.5.2.1 Cyberonics, Inc. Pipeline Products By Equipment Type1091
14.5.2.2 Cyberonics, Inc. Pipeline Products By Development Stage1091
14.5.2.3 Cyberonics, Inc. Pipeline Products By Therapy Area1091
14.6 ev3 Inc. 1101
14.6.1 Company Overview1101
14.7 B. Braun Melsungen AG 1101
14.7.1 Company Overview1101
14.8 Codman & Shurtleff, Inc1111
14.8.1 Company Overview1111
14.9 St. Jude Medical, Inc.1121
14.9.1 Company Overview1121
14.9.2 St. Jude Medical Inc. Pipeline Products1121
14.9.2.1 St. Jude Medical Inc. Pipeline Products By Equipment Type1122
14.9.2.2 St. Jude Medical Inc. Pipeline Products By Development Stage1141
14.9.2.3 St. Jude Medical Inc. Pipeline Products By Therapy Area1151
14.9.2.4 St. Jude Medical Inc. Pipeline Products By Clinical Trials1161
14.9.2.5 St. Jude Medical Inc. Pipeline Products By News Summary1171
14.10 Integra LifeSciences Holdings Corporation 1181
14.10.1 Company Overview1181
14.11 KARL STORZ GmbH & Co. KG1181
14.11.1 Company Overview1181
14.12 OLYMPUS CORPORATION1191
14.12.1 Company Overview1191
14.13 VYGON Neuro1191
14.13.1 Company Overview1191
14.14 Advanced Neuromodulation Systems, Inc.1201
14.14.1 Company Overview1201
15 Appendix1215
15.1 Global Markets Direct Research Methodology1211
15.2 Secondary Research1221
15.3 Primary Research1221
15.4 Models1231
15.5 Forecasts1231
15.6 Expert Panel Validation1231
15.7 Currency Conversion1241
15.8 Contact Us1251
15.9 Disclaimer1251

Enter the keyword(s) which you would like to search for within this document and click "Search"  


Price: $2,500.00



  Can't Decide?

Purchasing premium research sight unseen can be intimidating. At Alacra we want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.